Lexicon Pharma (LXRX) Tops Q4 EPS by 21c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.32 -0.85%
Financial Fact:
Total operating expenses: 62.65M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 62.65M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.31), $0.21 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $23 million versus the consensus estimate of $15.64 million.
As of December 31, 2016, Lexicon had $346.5 million in cash and investments, as compared to $395.6 million as of September 30, 2016 and $521.4 million as of December 31, 2015.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
